SCGE Shared Regulatory Documents

The Somatic Cell Genome Editing (SCGE) Consortium is an NIH Common Fund program created to accelerate translational research in genome editing. A primary goal is to disseminate documents generated through regulatory interactions between the U.S. Food and Drug Administration (FDA) and consortium projects to help the rare disease communities and the providers and researchers that serve them.